김유자

@Geovax_News @VistaPResearch 다이어트약이나 팔아아

With late-stage Mpox plans and Phase 2 COVID-19 trials, GeoVax is turning its strategy into measurable milestones. Read more insights from @JohnHeerdinkJr at @VistaPResearch: bit.ly/4tIQALf $GOVX

@Geovax_News @nytimes ㅋㅋㅋ슬슬 또 RS를 하기 위한 밑작업을 하나보네

GeoVax CEO David Dodd spoke with Rebecca Robbins from @nytimes to explore how the current vaccine environment is impacting fundraising and investor sentiment across the sector. Read it here: nyti.ms/4rjwNQZ $GOVX

@Geovax_News @Marketplace 혁신과는 거리가 먼 기업이지않나?

Vaccine innovation depends on long-term investment and clarity. In a recent @Marketplace interview, GeoVax CEO David Dodd shares how policy changes influence R&D priorities and impact future preparedness. 🎧 Listen to the full conversation: bit.ly/4r39NVL $GOVX

@Geovax_News ㅋㅋ다음 역분할은 언제인가요?

GeoVax endorsed a global call to sustain the mpox response, highlighting ongoing risks and the need for diversified vaccine supply and long-term preparedness. Read more: bit.ly/4axfYuJ $GOVX

@Geovax_News 전 이 회사때문에 1억을 잃었어요 조심하세요..다들

2026 marks a year of clinical and regulatory catalysts for GeoVax across multiple programs, supported by scalable manufacturing progress. Read the press release for our latest updates: bit.ly/4jRw1rx $GOVX

@Geovax_News @MDLinx 회사 문닫는 소식은 언제 알려줄꺼니?

Recent vaccine policy changes may increase confusion and infection risk in pediatric care. GeoVax CEO David Dodd notes the need to ensure “optional is not misinterpreted as unnecessary.” Read more from @MDLinx: bit.ly/4qvW2iw

@Geovax_News @wsbradio 이 회사는 돈을 쓰기만 하지, 벌지는 못합니다.ㅠ

GeoVax CEO David Dodd featured in @WSBRadio on workplace wellness: Employers increasingly offering on-site vaccines and health screenings as convenient healthcare access. "A healthier workforce benefits everyone." Read: bit.ly/497kpNp $GOVX

@Geovax_News ㅋㅋㅋㅋㅈㄹ dodd는 회사 돈을 어떻게 빼먹을까에 대한 발표나 하세요

GeoVax CEO David Dodd is looking forward to highlighting our differentiated pipeline and long-term growth strategy at #JPM26 this week. If you're interested in connecting with our team, send us a message. Catch up on our latest: bit.ly/4qclrxM $GOVX

BREAKING: AI just killed PowerPoint. Forget wasting time on designing each slide. Here are 5 AI tools to create stunning presentations in seconds:

@yojangman 오 생존 소식이라도 들으니 반갑네 너무너무 아쉽긴 하다. 최고였는데

그동안 마음 한켠에만 두었던 생각들 일기 쓰듯 끄적..

@PungkungzRich 진짜 쓰레기주식

$GOVX GeoVax Labs, Inc. (GOVX) will effect a one-for-twenty five (1-25) reverse split of its Common Stock. The reverse stock split will become effective on Monday, January 12, 2026. In conjunction with the reverse split

@Geovax_News Dodd야 너는 걸어서 다녀라 기름값 아깝다

$GOVX is heading to #JPM26. We look forward to connecting with the community & investors to discuss our clinical-stage programs in immunocompromised care, oncology and global vaccine preparedness. 📅 Jan 12-15, 2026 | 📍 San Francisco Message us to meet. geovax.com

@Geovax_News 하는 거라곤 돈 써재끼고 주가 나몰라라 리버스 스플릿 때리고 또 돈 쓰겠지 개새끼즐아

GeoVax is looking forward to highlighting 2025 operational achievements, clinical pipeline progress, and strategic priorities for 2026, including key clinical catalysts and regulatory milestones during #BiotechShowcase2026 and #JPM26. Details: bit.ly/4qclrxM $GOVX

@Geovax_News 니네 또 리버스 스플릿 하고 튈꺼잖아 개새꺄

GeoVax CEO David Dodd joined the Empowered Patient Podcast to discuss why multi-antigen, T-cell-focused vaccines are critical for immunocompromised patients who don’t respond to antibody-only vaccines. Listen to the full episode: bit.ly/4aMw9pZ $GOVX

@Geovax_News 주가가 0.18달러인 것에 대해 dodd는 설명 안하냐? 씹새꺄 주식회사가 뭔지 알긴 하냐

@Geovax_News 돈이나 벌어 쓰레기들아 돈쓰는거만 할거면 엄마아들로 살아

GeoVax’s GEO-MVA program progresses with EMA guidance, enabling a direct Phase 3 pathway, addressing emerging Mpox variants and global vaccine supply challenges. ICYMI: bit.ly/4pcsgOB $GOVX

@Geovax_News Dodd, act like a professional, not a student. Professionals focus on profit and outcomes, not just theories. It’s quite cringey to watch you act this way.

GeoVax announced publication of peer-reviewed study in Frontiers in Immunology demonstrating cross-variant protection using the multi-antigen GEO-CM04S1 vaccine. Read the study highlights: bit.ly/45gjCqW $GOVX

@elmar28x0 @Geovax_News 이 병신들은 돈을 쓰는 재주밖에 없습니다. Dodd 그는 평생 돈을 벌어본적이 없어요 ㅠ

@Geovax_News Another warrant… seriously? when are you guys actually going to generate revenue? #GOVX #Biotech #Investors #Dilution #Nasdaq #Stocks

GeoVax received formal Scientific Advice from the EMA confirming regulatory alignment on the proposed pivotal Phase 3 immunobridging trial design for GEO-MVA, its MVA-based vaccine candidate for Mpox and smallpox. Read more: bit.ly/4pPI1fq $GOVX

@Raycatlov3 ㅈ달기전에 만났으니 한 6~7년 전인가

@Geovax_News @stevegrubershow Dodd야 니는 회사가 어떻게 하면 수익을 낼지 연구하는 사람이란다. 주식회사의 뜻을 제대로 알길 바란다

GeoVax CEO David Dodd joins the @stevegrubershow to discuss why declining vaccination rates and COVID-era disruptions are putting the US at risk of losing its measles-free status. Listen here: bit.ly/3KGerJS #Vaccines #Measles #Healthcare